DAWN has been in the news 857% more than usual
Mar 06, 2026, 5:34 PM
0.00%
DAWN has been in the news recently: Day One Biopharmaceuticals, Inc. has been acquired by Servier for $21.50 per share in cash, totaling approximately $2.5 billion, which strengthens Servier's presence in pediatric glioma and broadens its oncology pipeline. In a broader market context, U.S. stocks experienced a decline, with the Dow Jones index falling about 500 points on the same day.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.